We are live on ! Find out more
TVGN icon

Tevogen Inc
TVGN

4 hedge funds and large institutions have $51.6M invested in Tevogen Inc in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

66.22% less ownership

Funds ownership: 96.5% → 30.28% (-66%)

86% less capital invested

Capital invested by funds: $358M → $51.6M (-$307M)

94% less funds holding

Funds holding: 65 → 4 (-61)

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 62

Holders
4
Holders Change
-61
Holders Change %
-93.85%
% of All Funds
0.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
1
Reduced
–
Closed
62
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$1.59M
2
UBS Group
UBS Group
Switzerland
+$6.37K

Top Sellers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
-$33.5M
2
Calamos Advisors
Calamos Advisors
Illinois
-$20.7M
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$18.8M
4
Millennium Management
Millennium Management
New York
-$17.8M
5
WAM
Weiss Asset Management
Massachusetts
-$15.4M

TVGN Hedge Fund Activity: Q1 2023 in Review

4 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc (TVGN) for Q1 2023, worth a combined $51.6M — down 86% from $358M a quarter earlier.

Sellers outnumbered buyers: 62 funds closed out of TVGN and 1 opened new positions — a net loss of 61 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $1.59M. The largest seller was Saba Capital Management, exiting entirely with an estimated $33.5M sold.

  • 4 institutional investors held Tevogen Inc (TVGN) as of Q1 2023, down from 65 in Q4 2022.
  • Funds reported $51.6M of Tevogen Inc stock for Q1 2023, down 86% quarter-over-quarter.
  • 1 fund opened new Tevogen Inc positions in Q1 2023 and 62 closed out, a net change of -61 holders.
  • The largest Tevogen Inc buyer in Q1 2023 was Cantor Fitzgerald, an estimated $1.59M added.
  • The largest Tevogen Inc seller in Q1 2023 was Saba Capital Management, an estimated $33.5M sold.

Based on aggregated 13F filings for Q1 2023.